Patient Guided Psychiatric Admissions

Schizophrenia Clinical Trial

Official title:

Patient Guided Psychiatric Admissions (Self-referral to Inpatient Beds)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01133587
• Other study ID #: 2009/1704
• Secondary ID: 2009/1704
• Status: Completed
• Phase: N/A
• First received: May 19, 2010
• Last updated: March 31, 2017
• Start date: May 2010
• Est. completion date: December 2013

Study information

• Verified date: March 2017
• Source: St. Olavs Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To meet the requirement for increased patient involvement, several Community Mental Health Centres (CMHC) have initiated a service called "patient-guided admissions". The investigators will compare a group with "patient guided admission/self-referral to inpatient beds" with a group having treatment as usual.

It is expected that patients in the intervention group will experience more increased feeling of coping (patient activation) after 4 months and 12 months as a result of participating in "patient-guided admissions" than patients getting treatment as usual. In addition the total number of inpatient days either in the CMHC, psychiatric hospital or community rehabilitation centre is expected to be clearly lower in the intervention group than in the 'treatment-as-usual' group during one year after intake. Also the number of involuntary admissions either as inpatient or outpatient will be significant lower in the intervention group than the 'treatment-as-usual' group.The number of admissions in CMHC and psychiatric hospital, as well as the number of outpatient consultations in primary care, CMHC and psychiatric hospitals, will be lower in the intervention group than in the 'treatment-as-usual' group. Patients in the intervention group will experience improved mental health, increased feeling of coping (patient activation) and increased experience of recovery after 4 months and 12 months as a result of participating in "patient-guided admissions".

Description:

Participants will be patients with psychosis or bipolar disorders. Patients in the intervention group will have a contract on "self-referral to inpatient beds" for one year. They can call the CMHC directly and ask for a bed for until 5 nights.

The patients in the 'treatment-as-usual' group will follow common procedures by either contacting their general practitioner, emergency department or duty doctor, and they will be offered a "self-referral to inpatient bed" contract after a year if they satisfy the inclusion criteria.

Regardless of the participation in the intervention group, the patients can also be ordinary admitted during the project period by a doctor via regular procedures in both hospital and CMHC if there is a need for this. All admissions will appear in the register data.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 53
• Est. completion date: December 2013
• Est. primary completion date: December 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• schizophrenia or bipolar disorder

• long term care

• established relationship with the ward

Exclusion Criteria:

• extensive substance use problems

• self-destructive behavior

• not able to consent

Related Conditions & MeSH terms

• Bipolar Disorder
• Schizophrenia

Intervention

Other:
• wait list control
Patient-guided admissions contract regarding "patient-guided admissions" starting a year after.

Behavioral:
• admissions contract
contract regarding "patient-guided admissions" starting immediately

Locations

Country	Name	City	State
Norway	St.Olavs hospital, Psykisk helsevern, Nidaros DPS	Trondheim

Sponsors (1)

Lead Sponsor	Collaborator
St. Olavs Hospital

Country where clinical trial is conducted

Norway, 

References & Publications (3)

Moljord IE, Helland-Hansen KA, Salvesen Ø, Olsø TM, Gudde CB, Rise MB, Steinsbekk A, Eriksen L. Short time effect of a self-referral to inpatient treatment for patients with severe mental disorders: a randomized controlled trial. BMC Health Serv Res. 2016 — View Citation

Moljord IE, Lara-Cabrera ML, Salvesen Ø, Rise MB, Bjørgen D, Antonsen DØ, Olsø TM, Evensen GH, Gudde CB, Linaker OM, Steinsbekk A, Eriksen L. Twelve months effect of self-referral to inpatient treatment on patient activation, recovery, symptoms and functi — View Citation

Sigrunarson V, Moljord IE, Steinsbekk A, Eriksen L, Morken G. A randomized controlled trial comparing self-referral to inpatient treatment and treatment as usual in patients with severe mental disorders. Nord J Psychiatry. 2017 Feb;71(2):120-125. doi: 10. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient activation/coping	Patient Activation Measure (PAM 13)	4 months
Primary	Patient activation/coping	Patient Activation Measure (PAM 13)	12 months
Secondary	Number of admissions	Number of admissions in CMHC, psychiatric hospital of community rehabilitation centre	12 months
Secondary	Total number of inpatient days	Total number of inpatient days in CMHC, psychiatric hospital or community rehabilitation centre	12 months
Secondary	Number of outpatient consultations	Number of outpatient consultations in primary care, in CMHC and psychiatric hospital	12 months
Secondary	Number of involuntary admissions	Number of involuntary admissions either as inpatient or outpatient	12 months
Secondary	Symptoms/functioning and recovery	Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)	4 months
Secondary	Symptoms/functioning and recovery	Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)	12 months